Literature DB >> 7270106

Hyperprolactinemic amenorrhea induced by metoclopamide (PrimperanR).

O P Andersen, P Hansen, H Madsen.   

Abstract

Secondary amenorrhea, elicited by metoclopamide (PrimperanR) induced hyperprolactinemia, was found in a 24-year-old woman. Withdrawal of the drug was followed by normalization of the hyperprolactinemia, as well as the menses. For many years metoclopamide (PrimperanR) has been used for various dyspeptic inconveniences, such as gastro-esophageal reflux, ventricular rentention and postoperative tarm-atom. Well-known secondary effects are reported to be drowsiness, uneasiness, restlessness and extra-pyramidal secondary effects in the form of acute dystom. The present case of secondary amenorrhea caused by metoclopamide (PrimperanR) induced hyperprolactinemia has been verified clinically, serologically and by treatment.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7270106     DOI: 10.3109/00016348109158145

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  3 in total

1.  Withdrawal effects of metoclopramide.

Authors:  A M Noll; D Pinsky
Journal:  West J Med       Date:  1991-06

2.  Metoclopramide-induced reversible impotence.

Authors:  R G Berlin
Journal:  West J Med       Date:  1986-03

Review 3.  Metoclopramide. An updated review of its pharmacological properties and clinical use.

Authors:  R A Harrington; C W Hamilton; R N Brogden; J A Linkewich; J A Romankiewicz; R C Heel
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.